Inhibition of son of sevenless homologue 1 (SOS1): promising therapeutic treatment for KRAS-mutant cancers

T Chen, X Tang, Z Wang, F Feng, C Xu, Q Zhao… - European Journal of …, 2023 - Elsevier
Kristen rat sarcoma (KRAS) is one of the most common oncogenes in human cancers. As a
guanine nucleotide exchange factor, Son of Sevenless Homologue 1 (SOS1) represents a …

Design and discovery of MRTX0902, a potent, selective, brain-penetrant, and orally bioavailable inhibitor of the SOS1: KRAS protein–protein interaction

JM Ketcham, J Haling, S Khare, V Bowcut… - Journal of Medicinal …, 2022 - ACS Publications
SOS1 is one of the major guanine nucleotide exchange factors that regulates the ability of
KRAS to cycle through its “on” and “off” states. Disrupting the SOS1: KRASG12C protein …

[HTML][HTML] Emerging Strategies in Mesenchymal Stem Cell-Based Cardiovascular Therapeutics

R Kumar, N Mishra, T Tran, M Kumar… - Cells, 2024 - mdpi.com
Cardiovascular diseases continue to challenge global health, demanding innovative
therapeutic solutions. This review delves into the transformative role of mesenchymal stem …

Comparative analysis of human induced pluripotent stem cell‐derived mesenchymal stem cells and umbilical cord mesenchymal stem cells

S Rajasingh, V Sigamani, V Selvam… - Journal of Cellular …, 2021 - Wiley Online Library
Generation of induced pluripotent stem cells (iPSCs) and their differentiation into
mesenchymal stem/stromal cells (iMSCs) have created exciting source of cells for …

Hutchinson-Gilford progeria patient-derived cardiomyocyte model of carrying LMNA gene variant c. 1824 C> T

S Perales, V Sigamani, S Rajasingh, A Czirok… - Cell and Tissue …, 2023 - Springer
Cardiovascular diseases, atherosclerosis, and strokes are the most common causes of
death in patients with Hutchinson-Gilford progeria syndrome (HGPS). The LMNA variant c …

Translational relevance of SOS1 targeting for KRAS‐mutant colorectal cancer

D Alem, X Yang, F Beato, B Sarcar… - Molecular …, 2023 - Wiley Online Library
It has been challenging to target mutant KRAS (mKRAS) in colorectal cancer (CRC) and
other malignancies. Recent efforts have focused on developing inhibitors blocking …

scaRNA20 promotes pseudouridylatory modification of small nuclear snRNA U12 and improves cardiomyogenesis

S Perales, V Sigamani, S Rajasingh… - Experimental Cell …, 2024 - Elsevier
Non-coding RNAs, particularly small Cajal-body associated RNAs (scaRNAs), play a
significant role in spliceosomal RNA modifications. While their involvement in ischemic …

[HTML][HTML] In-silico and in-vitro analysis of human SOS1 protein causing noonan Syndrome-a novel approach to explore the molecular pathways

V Sigamani, S Rajasingh, N Gurusamy, A Panda… - Current …, 2021 - ncbi.nlm.nih.gov
Aims Perform in-silico analysis of human SOS1 mutations to elucidate their pathogenic role
in Noonan syndrome (NS). Background NS is an autosomal dominant genetic disorder …

Translational potential of hiPSCs in predictive modeling of heart development and disease

C Mansfield, MT Zhao, M Basu - Birth defects research, 2022 - Wiley Online Library
Congenital heart disease (CHD) represents a major class of birth defects worldwide and is
associated with cardiac malformations that often require surgical intervention immediately …

The translational role of SOS1 in colorectal cancer

D Alem, X Yang, F Beato, B Sarcar, AF Tassielli, R Dai… - bioRxiv, 2022 - biorxiv.org
Background It has been challenging to develop agents directly targeting KRAS driver
mutations in colorectal cancer (CRC). Recent efforts have focused on developing inhibitors …